Clinical Trials
4 trialsNCT00482911 2017-03-27
Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT01216657 2013-06-04
Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic Melanoma
Krankenhaus Nordwest
Phase 2 Terminated
NCT00496223 2011-02-23
A Phase I/II Study of Sunitinib and Dacarbazine
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Terminated
NCT00304200 2009-02-05
Temodar and Sutent as Therapy for Melanoma
Northern California Melanoma Center
Phase 1/2 Terminated